Medical College of Wisconsin
CTSIResearch InformaticsREDCap

John A. Charlson MD

John A. Charlson MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Medicine Hematology Oncology

Member of the Cancer Center

View Curriculum Vitae

Publications (65)

  • Cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas: a multicentre, single-arm, lead-in phase 2 trial. (Monga V, Okuno S, Van Tine B, Pollack SM, Weiss M, Hirbe A, Viveiros P, Schulte B, Attia S, Siontis B, Milhem MM, Charlson JA, Robinson S, Okunowo O, Frankel P, Woo D, Yoon J, Agulnik M) Lancet Oncol 2026 Feb;27(2):223-232 PMID: 41554272 SCOPUS ID: 2-s2.0-105029655679 01/20/2026    
  • The impact of mental health disorders on healthcare utilization in cancer survivors. (Pierro M, Charlson JA) JCO Oncology Practice 14 October 2025;21:529-529 SCOPUS ID: 2-s2.0-105034158663 10/14/2025    
  • Neoadjuvant carboplatin/taxane (CbT) with or without doxorubicin/cyclophosphamide (AC) in real-world patients with early triple negative breast cancer (TNBC). (Schroeder MC, Viyyuri BR, McDougall D, Phadke SD, Charlson JA, Estrada-Merly N, Chapman CG, Neuner JM) Journal of Clinical Oncology June 2025;43:e23347-e23347 SCOPUS ID: 2-s2.0-105030506681 06/01/2025    
  • Review of Adoptive Cellular Therapies for the Treatment of Sarcoma. (Fradin JJ, Charlson JA) Cancers (Basel) 2025 Apr 12;17(8) PMID: 40282478 PMCID: PMC12026197 SCOPUS ID: 2-s2.0-105003535352 04/26/2025       4 Citations
  • Complementary and integrative medicine (CIM) use and association of self-efficacy with health behaviors and quality of life among survivors of sarcoma Cancer Survivorship Research and Care 04/07/2025    
  • Review of Adoptive Cellular Therapies for the Treatment of Sarcoma (Fradin JJ, Charlson JA) Cancers April 2025;17(8) SCOPUS ID: 2-s2.0-105003535352 04/01/2025       4 Citations
  • Cardiac MRI for differentiating chemotherapy-induced cardiotoxicity in sarcoma and breast cancer. (Ibrahim EH, Chaudhary L, Cheng YC, Sosa A, An D, Charlson J) Radiol Oncol 2025 Mar 01;59(1):79-90 PMID: 40014780 PMCID: PMC11867570 SCOPUS ID: 2-s2.0-86000078216 02/27/2025       1 Citation
  • Transmediastinal primary pulmonary liposarcoma: Case report and review of management strategies. (Wilcox T, Kleinertz A, Seadler BD, Joyce LD, Charlson J, Linsky PL) Rare Tumors 2024;16:20363613241274230 PMID: 39139396 PMCID: PMC11320392 SCOPUS ID: 2-s2.0-85201208219 08/14/2024    
  • Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. (D'Angelo SP, Araujo DM, Abdul Razak AR, Agulnik M, Attia S, Blay JY, Carrasco Garcia I, Charlson JA, Choy E, Demetri GD, Druta M, Forcade E, Ganjoo KN, Glod J, Keedy VL, Le Cesne A, Liebner DA, Moreno V, Pollack SM, Schuetze SM, Schwartz GK, Strauss SJ, Tap WD, Thistlethwaite F, Valverde Morales CM, Wagner MJ, Wilky BA, McAlpine C, Hudson L, Navenot JM, Wang T, Bai J, Rafail S, Wang R, Sun A, Fernandes L, Van Winkle E, Elefant E, Lunt C, Norry E, Williams D, Biswas S, Van Tine BA) Lancet 2024 Apr 13;403(10435):1460-1471 PMID: 38554725 PMCID: PMC11419333 SCOPUS ID: 2-s2.0-85188995845 03/31/2024       222 Citations
  • New phase 1 SURPASS trial cohort: Early-line ADP-A2M4CD8 T-cell receptor T-cell therapy plus pembrolizumab in urothelial carcinoma. (Aggen DH, Garcia A, Saro Suarez JM, Sauer A, Cristiani S, Brophy FE, Streets S, Norry E, Nelson AA, Kilari D, Garmezy B, Charlson JA, Zugazagoitia J, Calvo E, Moreno I, Moreno V, Hoimes CJ, Hong DS, Cervantes A) Journal of Clinical Oncology February 2024;42:TPS708-TPS708 SCOPUS ID: 2-s2.0-105024695982 02/01/2024       5 Citations
  • Pre-Operative Radiotherapy in STS: Does Downsizing Matter? (Gutkin PM, King DM, Charlson J, Wooldridge A, Hackbarth D, Kelly TR, Neilson J, Johnstone C, Bedi M) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):S148-S149 PMID: 37784375 10/03/2023    
  • Radiomics Model for Predicting Pulmonary Metastasis in Sarcoma Patients. (Prior PW Jr, Nasief HG, Mannem R, Charlson J, Fernando S, Bedi M) Int J Radiat Oncol Biol Phys 2023 Oct 01;117(2S):e708 PMID: 37786072 10/03/2023    
  • Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma. (Mittal S, Kadamberi IP, Chang H, Wang F, Kumar S, Tsaih SW, Walker CJ, Chaluvally-Raghavan P, Charlson J, Landesman Y, Pradeep S) Exp Hematol Oncol 2023 Sep 15;12(1):78 PMID: 37715291 PMCID: PMC10503035 SCOPUS ID: 2-s2.0-85171339411 09/16/2023       4 Citations
  • Medication self-management behaviors of adolescents and young adults with cancer. (Erickson JM, Kamke-Jordan A, Lancaster IJ, Palou-Torres A, Esch M, Gonzalez A, Charlson J, Bingen K) Support Care Cancer 2023 Jun 10;31(7):390 PMID: 37300714 PMCID: PMC10256968 SCOPUS ID: 2-s2.0-85163126078 06/10/2023       5 Citations
  • The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. (Heater NK, Okuno S, Robinson S, Attia S, Seetharam M, Siontis BL, Yoon J, Chawla S, Milhem MM, Monga V, Skubitz K, Charlson J, Hirbe AC, Weiss MC, Van Tine B, Agulnik M) J Clin Med 2023 Mar 29;12(7) PMID: 37048645 PMCID: PMC10095464 SCOPUS ID: 2-s2.0-85152939583 04/14/2023       2 Citations
  • Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors. (Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B) N Engl J Med 2023 Mar 09;388(10):898-912 PMID: 36884323 PMCID: PMC11225596 SCOPUS ID: 2-s2.0-85149934876 03/09/2023       8 Citations
  • Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy. (Gutkin PM, Gore E, Charlson J, Neilson JC, Johnstone C, King DM, Hackbarth DA, Wooldridge A, Mannem R, Bedi M) Radiat Oncol 2023 Mar 01;18(1):42 PMID: 36859309 PMCID: PMC9976442 SCOPUS ID: 2-s2.0-85149210071 03/02/2023       14 Citations
  • Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report (Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM) Brain Behavior and Immunity Health February 2023;27 SCOPUS ID: 2-s2.0-85144087911 02/01/2023       2 Citations
  • Abrupt onset of severe parkinsonism in a patient with metastatic gastrointestinal stromal tumor receiving treatment with avapritinib: A case report. (Drom C, Schenheit K, Matzke M, Obeidat AZ, Molinaro J, Charlson J, Knight JM) Brain Behav Immun Health 2023 Feb;27:100570 PMID: 36578920 PMCID: PMC9791578 SCOPUS ID: 2-s2.0-85144087911 12/30/2022       2 Citations
  • Leveraging Social Determinants of Health to Reduce Hospital Length of Stay: A Pilot QI Project for Solid Tumor Oncology Patients During the COVID-19 Pandemic. (Kamaraju T, Atkinson D, Wright T, Charlosn J, Wetzel T, Campbell G, Cadman J, Williams J, Egede L, Retseck J, Banerjee A, Ehrlich V, Stolley M, Power S) WMJ 2022 Oct;121(3):205-211 PMID: 36301647 SCOPUS ID: 2-s2.0-85140859344 10/28/2022       4 Citations
  • Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study. (Sridhar N, Glisch C, Jawa Z, Chaudhary LN, Kamaraju S, Burfeind J, Charlson J, Chitambar CR, Jorns JM, Cheng YC) J Cancer 2022;13(8):2472-2476 PMID: 35711833 PMCID: PMC9174868 SCOPUS ID: 2-s2.0-85130459904 06/18/2022       8 Citations
  • Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma. (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM) Adv Radiat Oncol 2022;7(3):100850 PMID: 35647402 PMCID: PMC9133395 SCOPUS ID: 2-s2.0-85127293946 06/02/2022       48 Citations
  • Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM) Advances in Radiation Oncology 1 May 2022;7(3) SCOPUS ID: 2-s2.0-85127293946 05/01/2022       49 Citations
  • Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas. (Ellison C, King DM, Neilson JC, Wooldridge A, Charlson JA, Hackbarth DA, Johnstone C, Bedi M) Am J Clin Oncol 2021 Dec 01;44(12):619-623 PMID: 34753886 SCOPUS ID: 2-s2.0-85120362291 11/11/2021       1 Citation
  • Value CMR: Towards a Comprehensive, Rapid, Cost-Effective Cardiovascular Magnetic Resonance Imaging. (Ibrahim EH, Frank L, Baruah D, Arpinar VE, Nencka AS, Koch KM, Muftuler LT, Unal O, Stojanovska J, Rubenstein JC, Brown SA, Charlson J, Gore EM, Bergom C) Int J Biomed Imaging 2021;2021:8851958 PMID: 34054936 PMCID: PMC8147553 SCOPUS ID: 2-s2.0-85107219799 06/01/2021       15 Citations
  • Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. (Schulte B, Mohindra N, Milhem M, Attia S, Robinson S, Monga V, Hirbe AC, Oppelt P, Charlson J, Helenowski I, Abbinanti S, Cehic R, Okuno S, Van Tine BA, Agulnik M) Br J Cancer 2021 Aug;125(4):528-533 PMID: 34050255 PMCID: PMC8368095 SCOPUS ID: 2-s2.0-85106671837 05/30/2021       17 Citations
  • High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. (Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN) Surgery 2020 Oct;168(4):760-767 PMID: 32736869 SCOPUS ID: 2-s2.0-85088789886 08/02/2020       8 Citations
  • A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas. (Monga V, Skubitz KM, Maliske S, Mott SL, Dietz H, Hirbe AC, Van Tine BA, Oppelt P, Okuno S, Robinson S, O'Connor M, Seetharam M, Attia S, Charlson J, Agulnik M, Milhem M) Cancers (Basel) 2020 Jul 11;12(7) PMID: 32664595 PMCID: PMC7408640 SCOPUS ID: 2-s2.0-85087813544 07/16/2020       46 Citations
  • Adolescents and Young Adults with Cancer Using a Symptom Heuristics App: Provider Perceptions and Actions. (Macpherson CF, Stegenga K, Erickson JM, Linder LA, Newman AR, Elswick RK, Charlson J, Thomas S, Ameringer S) J Adolesc Young Adult Oncol 2020 Oct;9(5):579-585 PMID: 32326804 PMCID: PMC7578178 SCOPUS ID: 2-s2.0-85092749707 04/25/2020       4 Citations
  • Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. (Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative) J Surg Oncol 2020 Jun;121(7):1140-1147 PMID: 32167587 SCOPUS ID: 2-s2.0-85081732672 03/14/2020       13 Citations
  • Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity? (Bedi M, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Cardona K, King DM) Clin Orthop Relat Res 2020 Mar;478(3):550-559 PMID: 32168066 PMCID: PMC7145071 SCOPUS ID: 2-s2.0-85081980953 03/14/2020       19 Citations
  • Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. (Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2020 Jan;245:577-586 PMID: 31494391 SCOPUS ID: 2-s2.0-85071720617 09/09/2019       3 Citations
  • Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. (Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD) Cancer 2019 Aug 01;125(15):2610-2620 PMID: 31173362 PMCID: PMC6771856 SCOPUS ID: 2-s2.0-85068993041 06/08/2019       68 Citations
  • The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. (Gannon NP, King DM, Ethun CG, Charlson J, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Votanopoulos K, Krasnick B, Fields RC, Cardona K, Bedi M) J Surg Oncol 2019 Sep;120(3):325-331 PMID: 31172531 SCOPUS ID: 2-s2.0-85070851045 06/07/2019       19 Citations
  • Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1. (Zarnecki KG, Kristianto J, Charlson J, Wilson B, Blank RD, Shaker JL) Osteoporos Int 2019 Aug;30(8):1699-1703 PMID: 31079185 SCOPUS ID: 2-s2.0-85065707987 05/13/2019       3 Citations
  • Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN) J Surg Res 2019 Jan;233:154-162 PMID: 30502242 SCOPUS ID: 2-s2.0-85051762456 12/07/2018       8 Citations
  • Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. (Charlson J) Curr Treat Options Oncol 2018 Oct 25;19(12):65 PMID: 30361919 SCOPUS ID: 2-s2.0-85055453382 10/27/2018       6 Citations
  • Primary angiosarcoma of the testis with retroperitoneal metastasis. (Piotrowski JT, Schaefer MB, Charlson JA, Iczkowski KA, Johnson SC) Urol Case Rep 2018 Nov;21:116-118 PMID: 30294549 PMCID: PMC6168964 SCOPUS ID: 2-s2.0-85054581757 10/09/2018       1 Citation
  • Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. (Yu PY, Beal EW, Hughes TM, Suarez-Kelly LP, Shelby RD, Ethun CG, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH) J Surg Res 2018 Nov;231:248-256 PMID: 30278937 SCOPUS ID: 2-s2.0-85048892540 10/04/2018       3 Citations
  • A novel, simplified, externally validated staging system for truncal/extremity soft tissue sarcomas: An analysis of the US Sarcoma Collaborative database. (Johnson AC, Ethun CG, Liu Y, Poultsides G, Howard JH, Bedi M, Charlson J, Tseng J, Roggin KK, Votanopoulos K, Cullinan D, Fields RC, Maithel SK, Cardona K, and other members of the US Sarcoma Collaborative) J Surg Oncol 2018 Dec;118(7):1135-1141 PMID: 30261111 SCOPUS ID: 2-s2.0-85053921013 09/28/2018       7 Citations
  • Postoperative Day 1 Glucose May Be Associated With Wound Complications in Sarcomas Treated With Preoperative Radiation. (Bedi M, King DM, Mendez C, Slawski B, Charlson JA, Hackbarth DA, Neilson JC) Clin Orthop Relat Res 2018 Mar;476(3):580-586 PMID: 29529645 PMCID: PMC6260049 SCOPUS ID: 2-s2.0-85056549830 03/13/2018       2 Citations
  • Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. (Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA) J Cancer Surviv 2018 Apr;12(2):268-275 PMID: 29243101 SCOPUS ID: 2-s2.0-85038093950 12/16/2017       10 Citations
  • Geographic Variation of Adjuvant Breast Cancer Therapy Initiation in the United States: Lessons From Medicare Part D. (Charlson JA, McGinley EL, Nattinger AB, Neuner JM, Pezzin LE) J Natl Compr Canc Netw 2017 Dec;15(12):1509-1517 PMID: 29223989 SCOPUS ID: 2-s2.0-85038431887 12/11/2017       4 Citations
  • Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. (Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC) Surgery 2018 Feb;163(2):318-323 PMID: 28943041 SCOPUS ID: 2-s2.0-85029656379 09/26/2017       40 Citations
  • Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy. (Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, Laud PW, Neuner JM) J Clin Oncol 2016 Dec 20;34(36):4398-4404 PMID: 27998232 PMCID: PMC5455308 SCOPUS ID: 2-s2.0-85009740911 12/22/2016       39 Citations
  • Preoperative Radiation Therapy Followed by Reexcision May Improve Local Control and Progression-Free Survival in Unplanned Excisions of Soft Tissue Sarcomas of the Extremity and Chest-Wall. (Saeed H, King DM, Johnstone CA, Charlson JA, Hackbarth DA, Neilson JC, Bedi M) Int J Surg Oncol 2016;2016:5963167 PMID: 27803813 PMCID: PMC5075633 SCOPUS ID: 2-s2.0-84993978494 11/03/2016       26 Citations
  • Bone Mineral Density Testing Disparities Among Patients With Breast Cancer Prescribed Aromatase Inhibitors. (Charlson J, Smith EC, Smallwood AJ, Laud PW, Neuner JM) J Natl Compr Canc Netw 2016 Jul;14(7):875-80 PMID: 27407128 SCOPUS ID: 2-s2.0-84978910683 07/14/2016       7 Citations
  • Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)? (Klooster B, Rajeev R, Chrabaszcz S, Charlson J, Miura J, Bedi M, Gamblin TC, Johnston F, Turaga KK) J Surg Oncol 2016 Jun;113(7):823-7 PMID: 27060344 SCOPUS ID: 2-s2.0-84963686460 04/10/2016       16 Citations
  • Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma. (Kashtan MA, Jayakrishnan TT, Rajeev R, Charlson JC, Johnston F, Clark Gamblin T, Turaga KK) Int J Clin Oncol 2016 Jun;21(3):602-8 PMID: 26646222 SCOPUS ID: 2-s2.0-84949484118 12/10/2015       4 Citations
  • Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4:531 PMID: 26413437 PMCID: PMC4577495 SCOPUS ID: 2-s2.0-84942305610 09/29/2015    
  • Biopsies in the Community Lead to Postoperative Complications in Soft Tissue Sarcomas. (Bedi M, King DM, Hackbarth DA, Charlson JA, Baynes K, Neilson JC) Orthopedics 2015 Sep;38(9):e753-9 PMID: 26375531 SCOPUS ID: 2-s2.0-84941278514 09/17/2015       4 Citations
  • Retroperitoneal solitary fibrous tumor: surgery as first line therapy. (Rajeev R, Patel M, Jayakrishnan TT, Johnston FM, Bedi M, Charlson J, Turaga KK) Clin Sarcoma Res 2015;5:19 PMID: 26322223 PMCID: PMC4551387 09/01/2015    
  • Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma. (Miura JT, Charlson J, Gamblin TC, Eastwood D, Banerjee A, Johnston FM, Turaga KK) Eur J Surg Oncol 2015 Oct;41(10):1386-92 PMID: 26251340 SCOPUS ID: 2-s2.0-84943818360 08/08/2015       81 Citations
  • Treatment differences between urban and rural women with hormone receptor-positive early-stage breast cancer based on 21-gene assay recurrence score result. (Andreason M, Zhang C, Onitilo AA, Engel J, Ledesma WM, Ridolfi K, Kim K, Charlson JC, Wisinski KB, Tevaarwerk AJ) J Community Support Oncol 2015 May;13(5):195-201 PMID: 26029936 PMCID: PMC4511377 SCOPUS ID: 2-s2.0-84973354109 06/02/2015       7 Citations
  • The introduction of generic aromatase inhibitors and treatment adherence among Medicare D enrollees. (Neuner JM, Kamaraju S, Charlson JA, Wozniak EM, Smith EC, Biggers A, Smallwood AJ, Laud PW, Pezzin LE) J Natl Cancer Inst 2015 Aug;107(8) PMID: 25971298 PMCID: PMC4580559 SCOPUS ID: 2-s2.0-84939643031 05/15/2015       44 Citations
  • Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. (Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM) Springerplus 2015;4(1):54 PMID: 25674506 PMCID: PMC4320689 SCOPUS ID: 2-s2.0-84923230004 02/13/2015       13 Citations
  • Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy (Dow EN, Piccolo J, Segal EM, Charlson JA) Cancer Treatment Communications 2015;4:161-164 SCOPUS ID: 2-s2.0-84947911220 01/01/2015       5 Citations
  • Drug induced periarticular thenar erythema with onycholysis related to nano-albumin bound paclitaxel therapy Cancer Treatment Communications 2015;4:161-164 01/01/2015    
  • Medicare Part D low-income subsidy and disparities in breast cancer treatment. (Neuner J, Smith E, Charlson JA, Pezzin L, Laud P) J Clin Oncol 2014 Oct 20;32(30_suppl):2 PMID: 28141273 10/20/2014    
  • The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery. (Bedi M, King DM, Whitfield R, Hackbarth DA, Neilson JC, Charlson JA, Wang D) Am J Clin Oncol 2015 Apr;38(2):184-8 PMID: 23563214 SCOPUS ID: 2-s2.0-84926408438 04/09/2013       12 Citations
  • Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. (Bedi M, King DM, Shivakoti M, Wang T, Zambrano EV, Charlson J, Hackbarth D, Neilson J, Whitfield R, Wang D) Radiat Oncol 2013 Mar 14;8:60 PMID: 23497372 PMCID: PMC3621722 SCOPUS ID: 2-s2.0-84874932091 03/19/2013       24 Citations
  • Multimodality management of metastatic patients with soft tissue sarcomas may prolong survival. (Bedi M, King DM, Charlson J, Whitfield R, Hackbarth DA, Zambrano EV, Wang D) Am J Clin Oncol 2014 Jun;37(3):272-7 PMID: 23275272 SCOPUS ID: 2-s2.0-84908046611 01/01/2013       19 Citations
  • A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer. (Yao X, Hosenpud J, Chitambar CR, Charlson J, Cheng YC) J Cancer 2012;3:145-51 PMID: 22481980 PMCID: PMC3319980 SCOPUS ID: 2-s2.0-84881202664 04/07/2012       13 Citations
  • Adamantinoma with plasmacytoid features: expanding the spectrum of a diagnostically challenging entity. (Walters MP, Baynes K, Carrera GF, King DM, Wang D, Charlson J, Zambrano E) Ann Diagn Pathol 2011 Oct;15(5):347-54 PMID: 20952283 SCOPUS ID: 2-s2.0-80052864102 10/19/2010       2 Citations
  • Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. (Fuller CK, Charlson JA, Dankle SK, Russell TJ) J Am Acad Dermatol 2010 Oct;63(4):e83-4 PMID: 20846560 SCOPUS ID: 2-s2.0-77956717395 09/18/2010       37 Citations
    • Last update: 04/13/2026